These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19690350)
1. Direct thrombin inhibitors in atrial fibrillation reloaded. Steffel J; Tanner FC Eur Heart J; 2009 Dec; 30(23):2832-4. PubMed ID: 19690350 [No Abstract] [Full Text] [Related]
2. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
3. New oral anticoagulants in atrial fibrillation. Turpie AG Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568 [TBL] [Abstract][Full Text] [Related]
4. Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties. Palagummi P; Saltzman H; Ezekowitz M Am Heart J; 2005 Jan; 149(1 Suppl):S32-5. PubMed ID: 15644791 [No Abstract] [Full Text] [Related]
6. Stroke prevention in atrial fibrillation: anticoagulants and antithrombotics. Ezekowitz MD Am Heart Hosp J; 2004; 2(4 Suppl 1):31-5. PubMed ID: 15539973 [TBL] [Abstract][Full Text] [Related]
7. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation. Halperin JL J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364 [TBL] [Abstract][Full Text] [Related]
8. Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Katira R; Chauhan A; More RS Postgrad Med J; 2005 Jun; 81(956):370-5. PubMed ID: 15937202 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. Hu D; Sun Y J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352 [No Abstract] [Full Text] [Related]
10. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation. Hammwöhner M; Goette A J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479 [TBL] [Abstract][Full Text] [Related]
12. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
13. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Diner BM Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695 [No Abstract] [Full Text] [Related]
14. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Savelieva I; Bajpai A; Camm AJ Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479 [TBL] [Abstract][Full Text] [Related]
15. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]
16. New anticoagulants: anti IIa vs anti Xa--is one better? Bauer KA J Thromb Thrombolysis; 2006 Feb; 21(1):67-72. PubMed ID: 16475045 [TBL] [Abstract][Full Text] [Related]
17. Another oral thrombin inhibitor for stroke prevention in atrial fibrillation? Eikelboom JW; Weitz JI Thromb Haemost; 2010 Mar; 103(3):481-3. PubMed ID: 20076857 [No Abstract] [Full Text] [Related]
18. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
19. Atrial fibrillation and anticoagulation. Garnier LF; Rouesnel P; Espitalier F Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178 [TBL] [Abstract][Full Text] [Related]
20. [Atrial fibrillation: new anticoagulants are more effective and safer, but expensive]. Steurer J Praxis (Bern 1994); 2014 Jun; 103(13):785-6. PubMed ID: 24938162 [No Abstract] [Full Text] [Related] [Next] [New Search]